Abstract:Objective Cutaneous lymphoma is the common group of extranodal non-Hodgkin lymphomas.18F-fluorodeoxyglucose(FDG) positron emission tomography(PET/CT) have been widely used in lymphoma.This research was to investigate the usefulness of FDG PET/CT in the management of cutaneous lymphoma.Methods The 12 patients with cutaneous lymphoma [nine T/NK cell non-Hodgkin lymphoma(NHL) and three B-cell NHL] were examined by PET/CT retrospectively.There were 9 men and 3 women(age range 16-79 years) who were performed PET/CT for initial staging and restaging following therapy.The patients were divided into 2 groups.Group A with 6 cases who had performed therapy before PET/CT scans,and Group B with 6 cases without therapy.All cases were followed up at least 6 months.Results Among group A,the 6 cases had performed 8 PET/CT scans,2 of 6 cases with negative PET/CT scan had not relapsed with follow-up more than 6 months.Four cases had positive PET/CT scans post-therapy.In group B,the 6 cases had performed with positive PET/CT results,however,2 of 6 cases with cutaneous lesions displayed negative FDG.Combined group A and B with positive PET/CT scans,there were cutaneous lesions in eight patients by visual inspection,however,2 patients with negative FDG PET/CT and another 2 patients with positive FDG PET/CT of partial cutaneous lesions;FDG PET had a sensitivity of 75% for the evaluation of cutaneous lesions by patients.For staging of cutaneous lymphoma,two patients were upstaged by FDG PET/CT compared with conventional methods.Conclusion FDG PET/CT has a potential value for initial staging and evaluating therapy reaction in patients with cutaneous lymphoma.

Preliminary application of 18F-FDG PET/CT in cutaneous lymphoma